Kate L. Mahon

119-143 Missenden Rd
Camperdown, NSW 2050, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Resuscitation plan documentation for medical oncology inpatients: a retrospective study.

Resuscitation plan documentation for medical oncology inpatients: a retrospective study.

Journal: BMJ supportive & palliative care

Published: November 29, 2025

International Prospective Quality of Life in Patients With Colorectal Peritoneal Metastases Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the United Kingdom and Australia.

International Prospective Quality of Life in Patients With Colorectal Peritoneal Metastases Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the United Kingdom and Australia.

Journal: Diseases of the colon and rectum

Published: June 10, 2025

Patterns and outcomes of disease recurrence after pelvic exenteration for locally recurrent rectal cancer.

Patterns and outcomes of disease recurrence after pelvic exenteration for locally recurrent rectal cancer.

Journal: The British journal of surgery

Published: March 16, 2025

Oligometastatic Disease Is Not an Absolute Contraindication to Pelvic Exenteration in Selected Patients With Locally Recurrent Rectal Cancer.

Oligometastatic Disease Is Not an Absolute Contraindication to Pelvic Exenteration in Selected Patients With Locally Recurrent Rectal Cancer.

Journal: Diseases of the colon and rectum

Published: December 27, 2024

The Paradox of Hope in Surgery for Advanced Gastrointestinal Malignancy: How Do We Define Futility?

The Paradox of Hope in Surgery for Advanced Gastrointestinal Malignancy: How Do We Define Futility?

Journal: Annals of surgery

Published: October 23, 2024

Plasma Lipidomic Profiling Identifies Elevated Triglycerides as Potential Risk Factor in Chemotherapy-Induced Peripheral Neuropathy.

Plasma Lipidomic Profiling Identifies Elevated Triglycerides as Potential Risk Factor in Chemotherapy-Induced Peripheral Neuropathy.

Journal: JCO precision oncology

Published: May 01, 2024

Clinical validation of circulating GDF15/MIC-1 as a marker of response to docetaxel and survival in men with metastatic castration-resistant prostate cancer.

Clinical validation of circulating GDF15/MIC-1 as a marker of response to docetaxel and survival in men with metastatic castration-resistant prostate cancer.

Journal: The Prostate

Published: June 06, 2023

Genomic Subtypes of Appendiceal Adenocarcinoma: Enough to Guide Clinical Decision Making?

Genomic Subtypes of Appendiceal Adenocarcinoma: Enough to Guide Clinical Decision Making?

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 18, 2023

BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotype.

BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotype.

Journal: EBioMedicine

Published: March 13, 2023

PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancer.

PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancer.

Journal: Prostate cancer and prostatic diseases

Published: November 15, 2022

From Research to the Real World: Moving Prostate Cancer Biomarkers into the Clinic.

From Research to the Real World: Moving Prostate Cancer Biomarkers into the Clinic.

Journal: Critical reviews in oncogenesis

Published: August 22, 2022

Modulation of Plasma Lipidomic Profiles in Metastatic Castration-Resistant Prostate Cancer by Simvastatin.

Modulation of Plasma Lipidomic Profiles in Metastatic Castration-Resistant Prostate Cancer by Simvastatin.

Journal: Cancers

Published: August 22, 2022

Showing 1-12 of 46

Last Updated: 09/26/2026